Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Activity of CM-101 in Patients With Systemic Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating CM-101 for systemic sclerosis has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• CM-101

Snippet

Sponsor: ChemomAb Ltd. | Conditions: Systemic Sclerosis | Phase 2 | Status: SUSPENDED